期刊文献+

基因芯片技术筛选血管瘤发生相关基因 被引量:2

Identification of differentially expressed genes in proliferating hemangiomas by cDNA microarray analysis of gene expression profiles
暂未订购
导出
摘要 目的:利用基因芯片技术寻找血管瘤与正常组织之间差异表达的基因,初步探索血管瘤的发生机制。方法:将14112条cDNA用点样仪点在特制玻片上制备成表达谱芯片,将来自同一患儿的血管瘤组织和正常组织的mRNA分别逆转录为cDNA,标记Cy3和Cy5两种荧光,制备成cDNA探针,与表达谱芯片杂交,通过计算机扫描、数据处理筛选出差异表达的基因。结果:血管瘤组织与正常组织共有249个差异表达基因,其中下调基因122个,上调基因127个。上调基因主要与细胞增生、血管形成、免疫细胞的黏附、细胞周期相关蛋白等有关;下调基因主要与细胞凋亡、肿瘤抑制等有关。结论:细胞增生相关基因的上调与凋亡相关基因的下调,导致细胞增生与凋亡失调,可能是引起血管瘤发病的原因。 Objective:To investigate the differentially expressed genes of proliferating hemangiomas and normal tissue by cDNA microarray analysis of gene expression profiles and to identify the key disease related genes.Methods:Samples were processed from total RNA and purified to mRNA,which was reverse transcripted and hybridized onto Biodoor Genechip expression microarrays.Gene expression analysis were performed to determine the differences between the proliferating hemangiomas and the normal tissue.Results:In proliferating hemangioma,122 genes were up-regulated and 127 genes were down-regulated.Those over-expressed gene were mainly related to cell proliferation,angiogenesis,and immune cell adhesion,cell cycle-related protein,while the less-expressed genes were mainly related to cell apoptosis and tumor suppression.Conclusions:Over-expression of genes related to cell proliferation and less-expression of cell apoptosis related genes lead to imbalance between cell proliferation and apoptosis,which probably lead to the occurrence of hemangiomas.
出处 《蚌埠医学院学报》 CAS 2008年第6期668-671,共4页 Journal of Bengbu Medical College
基金 安徽省教育厅自然科学研究资助项目(2005kj282)
关键词 血管瘤 基因芯片 发病机制 hemangioma gene chip pathogenesis
  • 相关文献

参考文献11

  • 1张莉,王炜,祁佐良,董佳生,宋怀东,杨劲松,林晓曦.用基因芯片研究同一血管瘤增生和消退期差异表达基因[J].中华整形外科杂志,2003,19(6):452-455. 被引量:11
  • 2Schena M,Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray [ J ]. Science, 1995,270 ( 5 235 ) :467 - 470.
  • 3Kawakubo T, Okamoto K, Iwata J, et al. Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface [ J ]. Cancer Res, 2007, 67(22) :10 869-10 878.
  • 4Seidler DG, Goldoni S, Agnew C, et al. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation [ J ]. J Biol Chem, 2006, 281 ( 36 ) : 26 408 -26 418.
  • 5Kota RS, Ramana CV, Tenorio FA, et al. Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon- gamma-mediated gene expression in human endothelial ceils[ J]. J Biol Chem,2005,280(35) :31 076 -31 084.
  • 6Mori T, Li Y, Hata H, et al. NIRF, a novel RING finger protein, is involved in cell-cycle regulation [ J ]. Biochem Biophys Res Commun,2002,296 (3) :530 - 536.
  • 7Vallon M, Essler M. Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha (v)beta3 to glycosaminoglycans [ J]. J Biol Chem,2006,281 (45) :34 179 - 34 188.
  • 8Liang TW, Chiu HH, Gurney A, et al. Vascular endothelialjunctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3 [ J]. J Immunol,2002, 168(4) :1 618- 1 626.
  • 9Koyama M, Otsuka H, Kusumi T, et al. Stem cell factor production from cultured nasal epithelial cells-effect on SCF production by drugs [ J 1. Nippon Jibiinkoka Gakkai Kaiho,2002,105 ( 2 ) : 166 - 173.
  • 10陈光,贺占国,王琪,王永海,成继民.毛细血管瘤组织中免疫细胞的分布变化及其意义[J].口腔医学,2000,20(1):14-15. 被引量:8

二级参考文献11

共引文献19

同被引文献34

  • 1刘静,廖洪斐.原发性眼眶肿瘤120例临床病理分析[J].国际眼科杂志,2007,7(2):447-449. 被引量:18
  • 2Arin K.Greene,M.D.,Patricia E.et al.Periorbital lymphatic malformation:clinical course and management in 42 patients[J].Plast Reconstr Surg,2005,115:23-30.
  • 3Shiels WE Kang DR,Murakami JW,et al.Percutaneous treatment of lymphatic malformations[J].Otolaryngol Head Neck Surg,2009,141:219-224.
  • 4Poonyathalang A,Preechawat P,Jiarakongmun P,et al.Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate[J].Jpn J Ophthalmol,2008,52:298-304.
  • 5Redlberger A,Ardelean M,Ebner J,Emesz M.Multicystic orbital tumor with displacement of the eyeball[J].Ophthalmologe,2008,105:949-951.
  • 6Mulliken JB,Fishman SJ and Burrows PE.Vascular anomalies[J].Curr Probl Surg,2000,37:519.
  • 7Lejoyeux,E.,Tulnsne,J.F.,and Tessier,P.LMaxillary growth following total septal resection in correction of orbital hypertelorism[J].Cleft Palate J,1986,23:27.
  • 8Donnelly LF,Bissot GS,Adams DM.Combined sonographic and fluoroscopic guidance:a modified technique for pewutaneous sclerosis of low-flow vascular malformations[J].Am J Roentgenol,1999,173:655-657.
  • 9Johnson PL,Eckard DA,Brecheison MA,et al.Percutaneous ethanol sclerotherapy of venous malformations of the tongue[J].Am J Neuroradiol,2002,23:779-782.
  • 10Svendsen P,Wikholm G,Fogdestam I,et al.Instillation of alcohol into venous malformations of the head and neck[J].Scand J Plast Reconstr Hand Surg,1994,28:279-284.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部